Update on survival from the original phase ii trial of bevacizumab and irinotecan in recurrent malignant gliomas.

October 6th, 2008 by admin

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Tags: , , ,

Posted in Cancer |

Related posts

Comments are closed.